The presence of extended-spectrum β-lactamase as a risk factor for MDR in clinical isolation of Escherichia coli

被引:0
|
作者
Asgharzadeh Kangachar, Sh [1 ]
Mojtahedi, A. [2 ]
机构
[1] Guilan Univ Med Sci, Fac Paramed, Langroud, Iran
[2] Guilan Univ Med Sci, Mol & Cellular Res Ctr, Fac Med, Rasht, Iran
关键词
URINARY-TRACT-INFECTIONS; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; PATHOGENS; PREVALENCE; INTEGRONS; PATTERNS; BACTERIA; STRAINS; SUSCEPTIBILITY;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Significant increases in antibiotic resistance have become a critical dilemma in healthcare systems around the world. Enterobacteriaceae acquired different mechanisms of antibiotic resistance such as ESBLs production and transposon attainment, which hold antibiotic resistance genes. This may create multidrug resistant (MDR) strains. Antibiotic resistance patterns vary in different geographical regions. The present estimated-cross sectional study is aimed to determine antibiotic resistance pattern of 182 E. coli strains to 20 antibiotics. Three different methods were applied to detect the ESBL-producing E. coli. Observations revealed that oxacillin, amoxicillin and ampicillin had the lowest effect, while imipenem, gentamicin and nitrofurantoin had the highest impact on clinical E. coli strains in our region. Three different methods, including double disk synergy test (DDST) (30 mm), double disk synergy test (DDST) (20mm) and combined disk test were used to identify ESBL-producing E. coli. The prevalence of ESBL producers was at a 35.71% rate. Findings of this study indicate that there is no significant difference between these three methods in identifying ESBLproducing E. coli. There was a significant relation between ESBL production and resistance to three other classes of antibiotics, including protein synthesis inhibitor, Quinolones and Metabolite analogues. Moreover, antibiotic resistance rate in ESBL-producing E. coli was significantly higher than non ESBL-producing isolates. The MDR was at a 65.93% rate. Unfortunately, the rate of antibiotic resistance is globally increasing; this is due to several factors such as inappropriate antibiotic use, incomplete course of antibiotics use, protracted length of stay in hospitals and self-medication. Resistance mechanisms such as ESBL production and MDR cause treatment failure. Our findings suggest that ESBL production is a risk factor for MDR in clinical E. coli. Therefore, Physicians are recommended to stop excessive and long term administration of antibiotics.
引用
收藏
页码:98 / 109
页数:12
相关论文
共 50 条
  • [21] Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
    Tuzun, Turkan
    Kutlu, Selda Sayin
    Kutlu, Murat
    Kaleli, Ilknur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 1206 - 1211
  • [22] RISK FACTORS FOR EXTENDED-SPECTRUM β-LACTAMASE-PRODUCING ESCHERICHIA COLI INFECTION IN HOSPITALIZED PATIENTS
    Ikeda, Yoshiaki
    Mamiya, Takayoshi
    Nishiyama, Hideki
    Koseki, Takenao
    Mouri, Akihiro
    Nabeshima, Toshitaka
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2012, 74 (1-2): : 105 - 114
  • [23] Risk Factors for Bloodstream Infections due to Extended-spectrum β-lactamase-producing Escherichia coli
    Wu, Un-In
    Yang, Ching-Shiang
    Chen, Wan-Chin
    Chen, Yee-Chun
    Chang, Shan-Chwen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2010, 43 (04) : 310 - 316
  • [24] Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing Escherichia coli From Companion Animals
    Bortolami, Alessio
    Zendri, Flavia
    Maciuca, Elena Iuliana
    Wattret, Andy
    Ellis, Christine
    Schmidt, Vanessa
    Pinchbeck, Gina
    Timofte, Dorina
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [25] Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli:: prevalence, risk factors and molecular epidemiology
    Rodriguez-Bano, Jesus
    Lopez-Cerero, Lorena
    Navarro, Maria D.
    Diaz de Alba, Paula
    Pascual, Alvaro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1142 - 1149
  • [26] Prevalence of qnr, intI, and intII genes in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from clinical samples in Iran
    Hadizadeh, Morteza
    Norouzi, Amin
    Taghadosi, Rohollah
    Mohebi, Samane
    Mohammadi, Mohsen
    Hasanzadeh, Amir
    Moghadam, Majid Taati
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (01) : 141 - 147
  • [27] Detection of Extended-spectrum β-lactamase and AmpC β-lactamase Producing Escherichia coli Isolates from Chickens
    Basaran Kahraman, Beren
    Diren Sigirci, Belgi
    Celik, Baran
    Gumus, Berna
    Metiner, Kemal
    Adiguzel, M. Cemal
    Bagcigil, A. Funda
    Ikiz, Serkan
    Ozgur, N. Yakut
    Ak, Seyyal
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2016, 22 (04) : 591 - 596
  • [28] First Detection of CTX-M-1 in Extended-Spectrum β-Lactamase-Producing Escherichia coli in Seafood from Tunisia
    Ben Said, Leila
    Hamdaoui, Mouna
    Jouini, Ahlem
    Boudabous, Abdellatif
    Ben Slama, Karim
    Torres, Carmen
    Klibi, Naouel
    JOURNAL OF FOOD PROTECTION, 2017, 80 (11) : 1877 - 1881
  • [29] Characterization of extended spectrum β-lactamase ( ESBL)-producing Escherichia coli in Asi (Orontes) River in Turkey
    Kurekci, Cemil
    Aydin, Muhsin
    Yipel, Mustafa
    Katouli, Mohammad
    Gundogdu, Aycan
    JOURNAL OF WATER AND HEALTH, 2017, 15 (05) : 788 - 798
  • [30] Molecular epidemiological of extended-spectrum β-lactamase producing Escherichia coli isolated in Djibouti
    Plantamura, Julie
    Bousquet, Aurore
    Vedy, Serge
    Larreche, Sebastien
    Bigaillon, Christine
    Delacour, Herve
    Merens, Audrey
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (08): : 753 - +